Through the analysis of TCF21, BUB1B, PINK1, and NR5A1 gene expression, we tested the value of this analysis to predict the OS of adult ACC and to distinguish between benign and malignant pediatric ACTs. This evidence concerns the gene TCF21 and adrenal cortex carcinoma.